NCT05899231

Brief Summary

Physical frailty is common in patients awaiting liver transplantation and has been associated with poor health outcomes. There is promising data from small studies showing that behavioural, nutrition, exercise therapy (prehabilitation) improves physical function in patients while they are waiting for a liver transplant. The proposed trial will assess if a 12-week online prehabilitation program improves physical function in patients listed for liver transplantation. Over 4 years, 177 patients will be recruited from 6 transplant centres across Canada and will be randomized to receive either the online prehabilitation program or usual care. The primary outcome of physical function will be evaluated using the FTSST at baseline and 12 weeks (or last timepoint before transplant) assessed virtually or in-person. Secondary outcomes include liver specific physical frailty, aerobic fitness, health-related quality of life (QoL), participant experience and acceptability. Exploratory outcomes include other virtual and in-person physical function measures, covert hepatic encephalopathy (CHE), sarcopenia, malnutrition, adherence, behaviour factors, clinical and post-transplant outcomes. Results will be compared between the intervention and usual care groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
177

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Jul 2023

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jul 2023Sep 2026

First Submitted

Initial submission to the registry

May 15, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

July 12, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

May 15, 2023

Last Update Submit

April 7, 2026

Conditions

Keywords

frailtytransplantnutritionexerciseehealthapplicationwellnessprehabilitationsarcopeniamalnutritionphysical functiondigitalvirtualonline

Outcome Measures

Primary Outcomes (2)

  • Change in time to do 5-sit-to-stands from baseline

    A time to complete 5 chair stands of \>15 seconds predicts morbidity and mortality in patients with cirrhosis. This test shows promise as a frailty measure that could be evaluated over a virtual platform

    Week 0

  • Change in time to do 5-sit-to-stands from baseline

    A time to complete 5 chair stands of \>15 seconds predicts morbidity and mortality in patients with cirrhosis. This test shows promise as a frailty measure that could be evaluated over a virtual platform

    Week 12

Secondary Outcomes (9)

  • Change in liver frailty index from baseline

    Week 0

  • Change in liver frailty index from baseline

    Week 12

  • Changes in virtual physical function testing over time (2-min step test)

    Week 0

  • Changes in virtual physical function testing over time (2-min step test)

    Week 12

  • Change in health-related quality of life from baseline (CLDQ)

    Week 0

  • +4 more secondary outcomes

Other Outcomes (47)

  • Change in time to do 5-sit-to-stands from baseline

    Week 8

  • Change in sarcopenia from baseline

    Week 0

  • Change in sarcopenia from baseline

    Week 12

  • +44 more other outcomes

Study Arms (2)

Prehabilitation Group

EXPERIMENTAL

The prehabilitation group will be provided with access to the online digital web platform which contains the weekly acceptance and commitment therapy based education videos, nutrition intervention, and exercise intervention.

Behavioral: Prehabilitation Programming

Usual Care

NO INTERVENTION

This group will receive standard care for LT candidates with cirrhosis and will be provided with standard online exercise, nutrition, and behavioural resources. Control participants will not receive access to the online digital platform.

Interventions

12-weeks of online prehabilitation programming including: 1.12 weeks of nutrition programming focused on achieving a guideline- based protein intake of 1.2-1.5 g/kg/day. Participants will participate in a dietitian assessment and 0-2 dietitian follow-ups stratified by risk and 5 virtual group nutrition classes. Participants will be provided with a whey protein powder supplement - dosing stratified by risk. 2.10 weeks of exercise programming focused on completion of 3 full- body resistance/aerobic exercise sessions weekly (1 or 2 virtual group classes as per patient preference + 1 or 2 pre-recorded home exercise videos). 3.12 weeks of acceptance and commitment therapy based educational videos and online activities focused on reducing stress and anxiety and improving motivation and adherence.

Prehabilitation Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old with cirrhosis (confirmed with transient elastography by FibroScan, histology, or imaging-based assessment with compatible clinical picture), referred for transplant and are assessed to have a high likelihood of being listed according to a preliminary review by hepatologist or are already listed for LT, are pre-frail or frail on the liver frailty index (LFI) or (added August 30, 2024) pre-frail or frail on the TeLeFI (prefrail LFI 3.2-4.3 and frail LFI ≥4.4), have English or French language proficiency, and own an internet-connected device.

You may not qualify if:

  • Listed for living related donor transplantation with expected time on the wait list \<12 weeks, or model for end-stage liver disease (MELD-Na) Score \>26 (Justification: time to transplant is very short)
  • Robust status on frailty testing (LFI 0-3.1) (Justification: unlikely to see benefit)
  • Unable to provide informed consent
  • Presence of a clinical condition that makes the intervention unsafe or infeasible (e.g. unable to follow instruction) or unsafe environment for virtual participation
  • Life expectancy less than 6 months, compassionate care (clinician judgment) (Justification: unlikely to see benefit)
  • Recent variceal bleed or history of varices not on adequate prophylaxis (Justification: acute exercise increases portal pressure
  • Transplant indication is cholangiocarcinoma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Foothills Medical Centre

Calgary, Alberta, T2N 2T9, Canada

RECRUITING

Kaye Edmonton Clinic

Edmonton, Alberta, T6G1Z1, Canada

RECRUITING

Gordon and Leslie Diamond Health Care Centre

Vancouver, British Columbia, V5Z 1M9, Canada

RECRUITING

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada

RECRUITING

Toronto General Hospital - Ajmera Transplant Centre

Toronto, Ontario, M5G 0A3, Canada

RECRUITING

McGill University Health Centre

Montreal, Quebec, H4A3J1, Canada

RECRUITING

MeSH Terms

Conditions

Liver CirrhosisLiver DiseasesFrailtyMotor ActivitySarcopeniaMalnutrition

Condition Hierarchy (Ancestors)

Digestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and SymptomsNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Puneeta Tandon

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2023

First Posted

June 12, 2023

Study Start

July 12, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations